Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases.
| Last: | $4.18 |
|---|---|
| Change Percent: | -1.3% |
| Open: | $4.19 |
| Close: | $4.235 |
| High: | $4.19 |
| Low: | $4.129 |
| Volume: | 15,861 |
| Last Trade Date Time: | 03/06/2026 12:37:06 pm |
| Market Cap: | $40,046,128 |
|---|---|
| Float: | 7,973,943 |
| Insiders Ownership: | 3.36% |
| Institutions: | 12 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.lisata.com |
| Country: | US |
| City: | Basking Ridge |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Lisata Therapeutics Inc. (NASDAQ: LSTA).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.